Follow
Asha Pillai
Asha Pillai
Chair, Hematology, Hematologic Malignancies, & Transplantation, Global Development, Regeneron
Verified email at regeneron.com - Homepage
Title
Cited by
Cited by
Year
Detectable minimal residual disease before hematopoietic cell transplantation is prognostic but does not preclude cure for children with very-high-risk leukemia
W Leung, CH Pui, E Coustan-Smith, J Yang, D Pei, K Gan, A Srinivasan, ...
Blood, The Journal of the American Society of Hematology 120 (2), 468-472, 2012
2232012
High success rate of hematopoietic cell transplantation regardless of donor source in children with very high-risk leukemia
W Leung, D Campana, J Yang, D Pei, E Coustan-Smith, K Gan, ...
Blood, The Journal of the American Society of Hematology 118 (2), 223-230, 2011
2072011
Host NKT cells can prevent graft-versus-host disease and permit graft antitumor activity after bone marrow transplantation
AB Pillai, TI George, S Dutt, P Teo, S Strober
The journal of immunology 178 (10), 6242-6251, 2007
1832007
Host natural killer T cells induce an interleukin-4–dependent expansion of donor CD4+CD25+Foxp3+ T regulatory cells that protects against graft-versus-host …
AB Pillai, TI George, S Dutt, S Strober
Blood, The Journal of the American Society of Hematology 113 (18), 4458-4467, 2009
1802009
NKT cells, Treg, and their interactions in bone marrow transplantation
HE Kohrt, AB Pillai, R Lowsky, S Strober
European journal of immunology 40 (7), 1862-1869, 2010
792010
Interleukin 3 is a growth factor for human follicular B cell lymphoma.
C Clayberger, S Luna-Fineman, JE Lee, A Pillai, M Campbell, R Levy, ...
The Journal of experimental medicine 175 (2), 371-376, 1992
511992
Risk-adapted donor lymphocyte infusion based on chimerism and donor source in pediatric leukemia
P Rujkijyanont, C Morris, G Kang, K Gan, C Hartford, B Triplett, M Dallas, ...
Blood Cancer Journal 3 (8), e137-e137, 2013
482013
CyTOF® for the Masses
A Iyer, AAJ Hamers, AB Pillai
Frontiers in immunology 13, 815828, 2022
392022
Recipient Myeloid-Derived Immunomodulatory Cells Induce PD-1 Ligand–Dependent Donor CD4+ Foxp3+ Regulatory T Cell Proliferation and Donor–Recipient Immune Tolerance After …
M Van Der Merwe, HA Abdelsamed, A Seth, T Ong, P Vogel, AB Pillai
The Journal of Immunology 191 (11), 5764-5776, 2013
312013
Diagnostic clues to human herpesvirus 6 encephalitis and Wernicke encephalopathy after pediatric hematopoietic cell transplantation
Z Sadighi, ND Sabin, R Hayden, E Stewart, A Pillai
Journal of child neurology 30 (10), 1307-1314, 2015
242015
Favorable preliminary results using TLI/ATG‐based immunomodulatory conditioning for matched unrelated donor allogeneic hematopoietic stem cell transplantation in pediatric …
A Pillai, C Hartford, C Wang, D Pei, J Yang, A Srinivasan, B Triplett, ...
Pediatric transplantation 15 (6), 628-634, 2011
242011
Globule leukocytes and other mast cells in the mouse intestine
P Vogel, L Janke, DM Gravano, M Lu, DV Sawant, D Bush, E Shuyu, ...
Veterinary pathology 55 (1), 76-97, 2018
222018
The weaned pig as a model for Doxorubicin-induced mucositis
J Martin, SC Howard, A Pillai, P Vogel, AP Naren, S Davis, ...
Chemotherapy 60 (1), 24-36, 2014
222014
Expanded human regulatory iNKT cells exhibit direct cytotoxicity against hematolymphoid tumor targets
W Luszczek, V Morales-Tirado, M van der Merwe, K Kudo, D Campana, ...
Cancer Research 72 (8_Supplement), 3512-3512, 2012
172012
Distinct mechanisms of innate and adaptive immune regulation underlie poor oncologic outcomes associated with KRAS-TP53 co-alteration in pancreatic cancer
J Datta, A Bianchi, I De Castro Silva, NU Deshpande, LL Cao, S Mehra, ...
Oncogene 41 (28), 3640-3654, 2022
152022
Successful allogeneic hematopoietic cell engraftment after a minimal conditioning regimen in children with relapsed or refractory solid tumors
DR Shook, BM Triplett, A Srinivasan, C Hartford, MH Dallas, A Pillai, ...
Biology of Blood and Marrow Transplantation 19 (2), 291-297, 2013
122013
Turning the tide for academic women in STEM: a postpandemic vision for supporting female scientists
A Shah, I Lopez, B Surnar, S Sarkar, LM Duthely, A Pillai, TT Salguero, ...
ACS nano 15 (12), 18647-18652, 2021
112021
A sweet alternative: maintaining M2 macrophage polarization
AAJ Hamers, AB Pillai
Science immunology 3 (29), eaav7759, 2018
102018
Phase I study of the safety and pharmacokinetics of plerixafor in children undergoing a second allogeneic hematopoietic stem cell transplantation for relapsed or refractory …
A Srinivasan, JC Panetta, SJ Cross, A Pillai, BM Triplett, DR Shook, ...
Biology of Blood and Marrow Transplantation 20 (8), 1224-1228, 2014
102014
Effects of conditioning regimens and T cell depletion in hematopoietic cell transplantation for primary immune deficiency
BM Triplett, C Wang, J Yang, M Dallas, C Hartford, V Howard, A Pillai, ...
Biology of Blood and Marrow Transplantation 18 (12), 1911-1920, 2012
92012
The system can't perform the operation now. Try again later.
Articles 1–20